World Aspergillosis Day 2026 took place on 3 February 2026, bringing together patients, researchers and healthcare professionals to share developments in aspergillosis research, diagnosis, treatment and patient care.
This page preserves the original programme and provides access to recordings of the presentations.
Watch the Presentations
Recordings from World Aspergillosis Day 2026, held on 3 February 2026, are now available to watch.
Watch the World Aspergillosis Day 2026 presentations on YouTube →
📅 NAC World Aspergillosis Day Meeting 2026
🗓 Tuesday 3 February 2026
👥 Open to patients, carers, clinicians, scientists, and anyone who lives or works with aspergillosis
🧬 This year’s theme:
“How can the genomics revolution help patients with chronic aspergillosis?”
MORNING: how can the ‘genomics revolution’ help chronic aspergillosis patients?
09:00 Teams meeting opens
09:30 Introductions
09:55 Welcome & intro (Beth)
10:15 What do patients want (and need) to know about genetics? (Lisa, Aspergillosis Trust)
10:45 Is there a ‘gene for CPA’? (Paul Bowyer, University of Manchester)
11:00 Primary immune defects that predispose to fungal infections (Graham, NAC, NHS)
11:30 Can CYP2C19 genotyping help voriconazole dosing? (Beth, NAC, NHS)
LUNCH
AFTERNOON: urgent gaps in patient knowledge
13:00 Patient story: ABPA and cortisol (Alison)
13:30 Raising awareness of Aspergillosis in Portugal (João Dias Cardoso)
14:15 Patient story: A ‘typical’ day in the life of an ABPA patient (Marcela, Portugal)
14:35 Patient story: Managing side effects of azole antifungals
14:45 A new toolkit for aspergillosis patients (Leah Linton, University of Exeter)
15:00 Meeting ends, but Teams will stay open for general discussion and socialising
Why genomics — and why now?
Modern molecular tests such as PCR and DNA sequencing are becoming faster, cheaper and more accurate. Because of this, the NHS is increasingly exploring how genomic technologies can be used to improve diagnosis, monitoring and treatment across many diseases — including aspergillosis.
This year’s WAD meeting will start an open discussion between patients and professionals about which genomic and molecular tests are likely to matter most for people with aspergillosis in the years ahead.
Topics will include:
-
🧠 Is there a “gene for aspergillosis”?
Should people be tested for genetic susceptibility? -
💊 Genes and voriconazole dosing
Can testing the CYP2C19 gene help personalise antifungal treatment? -
🦠 Tracking antifungal resistance
How molecular testing of Aspergillus strains can help hospitals monitor resistance. -
🔬 Aspergillus PCR at NAC
How PCR is already used to diagnose and monitor chronic aspergillosis.
🗣️ Patient voices at the heart of the meeting
As always, patient experience will be central to the day.
This year will include new patient stories, including Alison, who will talk about how her aspergillosis treatment led to the development of adrenal insufficiency, and what that has meant for her care and daily life.
“I don’t know anything about genetics — is this for me?”
Absolutely yes.
You don’t need any background in genetics to take part. Everything will be explained clearly, step by step, with minimal jargon.
Planned discussion topics include:
-
What do my Aspergillus PCR test results actually mean?
-
Is there really a “gene for CPA”?
-
Why do genes matter for antifungal dosing?
In fact, the more questions you ask — especially the “silly” ones — the better. The discussion from the day will be used to create a new patient leaflet, designed to help people better understand their diagnosis and test results.
We hope you can join us for World Aspergillosis Day 2026 — to learn, to ask questions, and to help shape the future of aspergillosis care together.
Did this page help you?
Tell us in one minute
